RAPP Sale Disclosure
Ceesay Abraham · SEC Form 4 · Filed Oct 23, 2026
Sale
Calculated transaction value
$64.45K
Ceesay Abraham Chief Executive Officer
RAPP
Rapport Therapeutics
RAPP
Transaction date
Oct 21, 2026
Public filing date
Oct 23, 2026
Filing lag
Filed 2 days later
RAPP daily price context
Close on/before transaction
$25.06
Oct 21, 2026
First close after public filing
$25.33
Oct 26, 2026
Return after filing · so far
+2.92%
Through Nov 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,210 shares @ $29.16
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-430504
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$64.45K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP Current | Sale | Oct 21, 2026 | $64.45K |